Pathophysiological Consequences of a Break in S1P1-Dependent Homeostasis of Vascular Permeability Revealed by S1P1 Competitive Antagonism-Reference-Cited by-同舟云学术

Pathophysiological Consequences of a Break in S1P1-Dependent Homeostasis of Vascular Permeability Revealed by S1P1 Competitive Antagonism

Published:2016-12-22 Issue:12 Volume:11 Page:e0168252
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Bigaud Marc,Dincer Zuhal,Bollbuck Birgit,Dawson Janet,Beckmann Nicolau,Beerli Christian,Fishli-Cavelti Gina,Nahler Michaela,Angst Daniela,Janser Philipp,Otto Heike,Rosner Elisabeth,Hersperger Rene,Bruns Christian,Quancard Jean

Funder

Novartis Institutes for Biomedical Research

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference37 articles.

1. Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology;V Brinkmann;Pharmacol Ther,2007

2. Chemical modulators of sphingosine-1-phosphate receptors as barrier oriented therapeutic molecules;D Marsolais;Nature Reviews,2009

3. Sphingosine 1-phosphate (S1P): physiology and the effects of S1P receptor modulation;T Hla;Neurology,2011

4. Tonic regulation of vascular permeability;FR Curry;Acta Physiol,2013

5. In vitro and in vivo modulation of vascular barrier integrity by sphingosine 1-phosphate: mechanistic insights;BJ McVerry;Cell Signal,2005

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. S1PR1 attenuates pulmonary fibrosis by inhibiting EndMT and improving endothelial barrier function;Pulmonary Pharmacology & Therapeutics;2023-08

2. Magnetic resonance imaging and ultrasound elastography in the context of preclinical pharmacological research: significance for the 3R principles;Frontiers in Pharmacology;2023-06-28

3. Rationale for Use of Sphingosine-1-Phosphate Receptor Modulators in COVID-19 Patients: Overview of Scientific Evidence;Journal of Interferon & Cytokine Research;2022-11-29

4. Silence of S1PR4 Represses the Activation of Fibroblast-like Synoviocytes by Regulating IL-17/STAT3 Signaling Pathway;Inflammation;2022-09-06

5. Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway Modulators, from Current Insights to Future Perspectives;Cells;2022-06-29